chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About a week after my 2nd vaccine, the first week in Sept,  I developed the first symptoms of Parosmia and Disgeusia. I began smelling smoke that wasn't there. Then slowly, foods started tasting horrible. Things I love, like coffee and chocolate suddenly smelled horrible, and tasted putrid. Then on Halloween, all the candy tasted and smelled awful. From there this thing took a fast downward spiral. I didn't know what I could eat, or where I could "safely" breathe. Nearly all smells and tastes made me vomit. I dropped weight rapidly. There were about 12 "safe" foods left for me by the time this thing stopped getting worse. Everything, in the beginning, that was bad, had the same exact smell and taste/flavor, regardless of what it was. Chocolate, Lettuce, meat, rice, (and nearly everything else I used to eat) all tasted exactly the same, and it was horrible. I'm almost 10 months into this and I still have about 12-15 foods. I cant go out to eat anywhere. I can't eat with my family. No family BBQs. I can't enjoy a walk outside in the spring, or go shopping in the mall, or even many grocery stores because the smells are so bad. I'm isolated. There is no known treatment that's guaranteed to work. Most doctors have never even heard of this. It's taken away so much of my livelihood.
Patient reported on 1/03/2020 that 2nd dose of Shingrix administered on 12/30/2019 caused patient severe swelling and soreness at arm, high fever, nausea, lack of appetite, shivering,headache and extreme sweating (1 night after IMZ). Symptoms began 24 hours after administration and lasted 12/31-01/02. I counseled patient that these are listed as possible side effects.  However patient felt they were 3 times more severe than she felt on the 1st dose given on 09/13/2019. Patient says she loss weight due to lack of appetite and feeling ill. Patient had to rest at home and could not participate in regular activities. Patient reported that the symptoms tend to worsen in the afternoon and subsides in the morning each day. Patient almost went to the ER but did not. Patient resolved with home OTC medication. Patient did not reach out to MD to consult. Patient requested this to be reported as an adverse event in case there is an issue with the batch.  Batch #2B3P2 Exp date 05/10/2022
Diffuse maculo-papular rash all of left upper arm and associated swelling and burning.
Unknown effects,  No known effects currently, however, infant was given oral rotavirus was given intramuscular .
exhaustion, 4-hour nap needs the day after first Shingrix  shot.
pain of the injection site after booster dose; tenderness of the injection site after booster dose; fatigue after booster dose; headache after booster dose; chills after booster dose; muscle pain after booster dose; joint pain after booster dose; nausea after booster dose; slight fever after booster dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain of the injection site after booster dose), VACCINATION SITE PAIN (tenderness of the injection site after booster dose), FATIGUE (fatigue after booster dose), HEADACHE (headache after booster dose) and CHILLS (chills after booster dose) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034F21A, 007M20A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Blood pressure abnormal and Cholesterol. Concomitant products included MELOXICAM for Pain.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain of the injection site after booster dose), VACCINATION SITE PAIN (tenderness of the injection site after booster dose), FATIGUE (fatigue after booster dose), HEADACHE (headache after booster dose), CHILLS (chills after booster dose), MYALGIA (muscle pain after booster dose), ARTHRALGIA (joint pain after booster dose), NAUSEA (nausea after booster dose) and PYREXIA (slight fever after booster dose). At the time of the report, VACCINATION SITE PAIN (pain of the injection site after booster dose), VACCINATION SITE PAIN (tenderness of the injection site after booster dose), FATIGUE (fatigue after booster dose), HEADACHE (headache after booster dose), CHILLS (chills after booster dose), MYALGIA (muscle pain after booster dose), ARTHRALGIA (joint pain after booster dose), NAUSEA (nausea after booster dose) and PYREXIA (slight fever after booster dose) outcome was unknown.            Concomitant medications include blood pressure and cholesterol. No treatment medication use was reported.   This case was linked to MOD-2021-402843, MOD-2021-402856 (Patient Link).   Reporter did not allow further contact
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Severe, Systemic: Hypotension-Medium, Systemic: Nausea-Medium
CHILDS DOB LIST ON CONSENT DOES NOT MATCH DOB IN DATABASE. CHILD UNDERAGE FOR VACCINE.
This spontaneous report was received from a nurse and refers to 2 patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX lot # L017142, expiration date 13-MAY-2017 (exact dose and route of administration were not reported). No adverse effects were reported. Administered doses of vaccines experienced the temperature excursion of -7.1 degrees Celsius (C) for 2 hours 2 minutes on 10-AUG-2016 and -8.1 C for 1 hour 14 minutes on 25-AUG-2016 (cumulative: maximum -7.1 C for 3 hours 16 minutes). There was no prior excursions. Data logger was involved. This is one of several reports received from the same reporter. Additional information has been requested.
According to mom, pt cried for 3 hrs p/receiving 2nd dose of DTP on 3DEC90; Taken to ER 3DEC90 in PM;
04/19/2021 In the morning at 10:00, I got my shot, after 10-15 my arm was numb, I felt my cheek was hurting. The pain was traveling all over my face. I got like a headache. I wasn't really sure what it was. The pain traveled all over my head and face. I felt like someone punched me on my eyes. My face was swollen. I called my doctor by telemedicine I told him everything and he said it was a reaction from the vaccine. It looked like I had bell's palsy. I went to the doctor she did some test but it was negative. I went to the neurologist she said after couple of tests she said I had trigeminal neuralgia. she gave me medications to take muscle relaxer. I took it for few days and started feeling better. Sometimes I still feel it.
Fever of 103 degrees. Runny nose.  As of this date 10/19/2009 patient is still not well, fever, runny nose.
Fever, chills, shivers, nausea, fatigue, "tight breathing", tachycardia.
Approx. 4 hours after vaccine patient became light headed, saw stars & had a seizure. This resulted in an ambulance called and further workup in the intensive care unit findings of a left parietal bleed.
1. Fatigue lasting about 3 days 2. Soreness, stiffness, and redness at the injection site lasting about 6 days
Initial misuse report received from a healthcare professional on 13 November 2013. On unspecified date a 62 year old patient received FLUZONE HD vaccine. Drug administered to patient of inappropriate age. No adverse event was reported. List of documents held by sender: none.
had acute bronchitis @ this time. Hx of asthma; recv vax; first noted difficulty w/ balance late Nov.  Increasing vertigo, weakness, numbness of the face, low back, extremities, esp. finger-tips. Dx GBS.
Info has been received from a registered nurse concerning a 48 year old female who on 11/11/2002 was vaccinated with a 1st dose of pneumococcal vaccine 23 polyvalent (site and route not reported). On 11/12/2002 the pt noted redness and swelling at the injection site that spread up her arm to her neck. On 11/13/2002 on examination it was noted her lymph nodes were swollen. At this time the pt has not been re-evaluated. The pt sought unspecified medical attention. Additional info has been requested.
Mother noticed redness, swelling on 04/07/05 in the evening. Redness decreased by 04/08/05
4/6: The vaccine burned as it went in. The nurse at the Pharmacy administering the vaccine made the comment: "Oh, that's weird. Everyone who has gotten this batch (Johnson&Johnson) today have complained of burning." 4/7: Experienced severe body aches, chills, nausea, sweat, and vomiting. Headache that lasted all day.  4/8- 4/9: A mild headache that waxed and waned. 4/10: After drinking four alcoholic drinks between 10A to 2P, about an hour apart each, I became violently ill. By the second drink I felt a little sick but passed it off for being outside in the sun. Not being told that we shouldn't drink after the vaccine I didn't consider that I shouldn't. Throughout the day I experienced several blackouts, nausea, chills and a severe headache that lasted until 2A until I was finally able to go to sleep. This was absolutely terrifying as I have never experienced anything like this. I have bits and pieces completely gone of this day. I did not drink enough to black out, nor have I ever experienced blackouts or ever drank enough to cause me to black out. I do believe this is connected directly to the vaccine. 4/11: The headache remained as well as dizziness and nausea. 4/12: The headache waxed and waned along with the nausea. 4/13: I still have a headache and mild nausea.
Gave a Moderna monovalent COVID vaccine (NDC  80777-0273-98) on day 38 of it being put in the refrigerator, so 8 days after the BUD; Product storage error; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Gave a Moderna monovalent COVID vaccine (NDC  80777-0273-98) on day 38 of it being put in the refrigerator, so 8 days after the BUD), PRODUCT STORAGE ERROR (Product storage error) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Gave a Moderna monovalent COVID vaccine (NDC  80777-0273-98) on day 38 of it being put in the refrigerator, so 8 days after the BUD), PRODUCT STORAGE ERROR (Product storage error) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Gave a Moderna monovalent COVID vaccine (NDC  80777-0273-98) on day 38 of it being put in the refrigerator, so 8 days after the BUD), PRODUCT STORAGE ERROR (Product storage error) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Gave a Moderna monovalent COVID vaccine (NDC  80777-0273-98) on day 38 of it being put in the refrigerator, so 8 days after the BUD) and PRODUCT STORAGE ERROR (Product storage error).    The concomitant medication was not reported by reporter. The treatment medication was not reported by reporter.
I had bad muscle cramps in leg(s) and fainted at about 6 am one morning while sleeping.  I think work stress was a contributing and perhaps precipitating factor.  I later had similar cramps when I contracted covid 19 in September, so do suspect the vaccine had something to do with it.  I have fainted several times in my life, but my wife did call my father,  a doctor when I fainted.  About a month later, I went in for a routine check in to make sure everything was fine.  I got my booster this week and am fine.  Would not have filed this report but for a call from cdc this morning.  I am glad I got the vaccine, but it is a fact I fainted.  What exactly caused the fainting is probably not something I can say for sure.  If others are having similar reactions, perhaps it is something that should be looked into.
Patient called me 7/21/21 to report having experienced chest pain beginning 5-6 hours after the Covid injection.  The following day the chest pain continued so he was evaluated by a nurse on site at him employer.  She felt it was likely due to the vaccination and not an immediate cardiac concern. He called me to simply make me aware of his experience so I may report it.  The pain had let up a bit but still continued at this time.
3 days after patient received shingles vaccine, developed burning pain around base of spine. By 3 days later she developed pronounced soreness in vaginal and rectal areas. 2 days later she noticed a lump and visual redness in the above affected areas. Pain continued. Patient seen by physician 5/13/17. Diagnosed with shingles, treated with acyclovir x 7 days.
Brain fog that started approx two weeks after 2nd dose of Pfizer vaccine. Symptoms include mild/low forgetfulness that is consistent, new, ongoing, occurs daily, noticeable.
pt has hx of recent humeral fracture & recv 1dose of varivax 6/97 & in 4/98 pt was dx w/shingles "midway between her elbow & shoulder @ dermatome C8; pt has cast on this arm." treated w/cortisone.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 19-APR-2012, the patient was inoculated with the ZOSTAVAX (lot number, dosage, and route of administration not provided), at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 14-JAN-2016, the patient was treated by a physician for a persistent and severe vesicular rash, which was diagnosed as zoster. The patient was prescribed NEURONTIN to manage and ease his painful symptoms and chronic pain. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Bruise on the injection site/bruise around the area of the vaccine; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3248; Expiration date was not reported) in Jan2021 at a single dose, with route of administration unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. In Jan2021, after the first dose of vaccination, the patient had bruise on the injection site/bruise around the area of the vaccine. The outcome of the event, bruise on the injection site/bruise around the area of the vaccine, was not recovered.
2 wks after the injection 1/30/21 the site of the injection is red and itches tremendously.  today 1/31/21 it is still itching.
PUI has a host of illnesses Leukemia Diabetes had open heart surgery three heart attacks Pneumonia and is in ICU. Fully vaccinated.
This spontaneous report as received from a pharmacist refers to 2 patients of unknown age and gender. On 20-SEP-2014 those patients were vaccinated with an expired dose of PNEUMOVAX23 (lot # H010515, expiry date: 13-FEB-2014, dose, units, route of administration, anatomical location were not reported). No adverse effects reported. Additional information has been requested.
Raised hives continue to appear on body at random. Uncontrollably itchiness causes global rashes throughout entire body. Last for about an hour and then subsides. Continues to persist until I take Zyrtec. Doctor prescribed steroids however the symptoms continue to persist.
arm became itchy; arm had smooth red area; arm had hard area; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at injection site), VACCINATION SITE PRURITUS (arm became itchy), VACCINATION SITE ERYTHEMA (arm had smooth red area) and VACCINATION SITE INDURATION (arm had hard area) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain at injection site). On 07-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (arm became itchy), VACCINATION SITE ERYTHEMA (arm had smooth red area) and VACCINATION SITE INDURATION (arm had hard area). On 01-Apr-2021, VACCINATION SITE PAIN (pain at injection site) had resolved. At the time of the report, VACCINATION SITE PRURITUS (arm became itchy), VACCINATION SITE ERYTHEMA (arm had smooth red area) and VACCINATION SITE INDURATION (arm had hard area) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
vision loss; herpes zoster ophthalmicus; herpes zoster; This spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient (pt) of unknown age and gender. The pt's medical history, concurrent conditions and concomitant medications were not reported.  On or about 17-JUL-2010, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) in a pharmacy (exact dose, site and route of administration, lot# and expiration date were not reported) for the long-term prevention of shingles and zoster-related conditions. Subsequently, on an unknown date, the pt was treated for the following injuries resulting from zoster vaccine live (ZOSTAVAX) use: herpes zoster, vision loss, eye pain and herpes zoster ophthalmicus. The outcome of the events was unknown. The relatedness between the events and zoster vaccine live (ZOSTAVAX) was related.  Upon internal review, the events of vision loss and herpes zoster ophthalmicus were determined to be medically significant.
Left side of arm; felt warm to the touch, redness to the area and felt a little stiff, was advised to start applying compressions to site.
This spontaneous report was received from a nurse regarding to an unknown age patient. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 29-JAN-2018, the patient was inadvertently vaccinated with one expired dose of VARIVAX (Lot # M002064 with expiration date 12-JAN-2018) for prophylaxis (dose number and route of administration were not reported). No adverse effects reported.
Child developed a rash in their mouth; This spontaneous report was received from a registered nurse, concerning a 12-month-old patient of unknown gender. Information regarding the patient's medical history, concurrent conditions, drug reactions or allergies, and concomitant medications was not provided.  On an unknown date, the patient was vaccinated concomitantly with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection; and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, (strength, lot #, expiry date, and route of administration were not provided). Both vaccines were administered for prophylaxis at their 12-month visit.  On an unspecified date, the child developed rash in their mouth (oral mucosal eruption). At the time of reporting, the outcome of the event was unknown.  It was not confirmed if the healthcare professional was interested in requesting to obtain a sample and sending isolates for an analysis.  The causal relationship between the event of oral mucosal eruption, varicella virus vaccine live (oka/merck) (VARIVAX), and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was unknown.  This is one of two cases received from the same reporter.; Sender's Comments:  US-009507513-2208USA004153:Splitted case
Patient passed out in the store after receiving the vaccination. No injuries noted. She stated that all she had eaten all day was a piece of toast. Store called EMS who then evaluated patient and she sat around for awhile and then left the store.
This spontaneous report as received from a nurse practitioner refers to a 15 weeks old patient. The patient was vaccinated with a 2 l dose of live, oral ROTATEQ (lot # not reported) on 26-NOV-2012 at 15 weeks and 2 days of age. No other co-suspects were reported. No concomitant medications were reported. Additional information has been requested.
pt exp itchy raised rash all over back on 16MAY92 following dose #1 of Engerix-B;
RASH ALL OVER THE BODY INCLUDING FACE. ITCHING ALL OVER. IT LOOKED LIKE CHICKEN POX. THE RASH LASTED FOR 3 WEEKS WITH NO RELIEF.  NO MEDICATION WAS PRESCRIBE FOR THESE SYSMPTOMS.
Patient had redness/pain that went up arm and started at neck that was diagnosed at cellulitis at ER , she experienced fever, nausea, headache and flu like symptoms.
Immunization: COVID-19 PFizer-BioNtech 12yrs-adult, external - Pfizer vaccine was administered outside of our facility - reported by patient  J96.00 ACUTE RESPIRATORY FAILURE 1/9/2022 ADVANCE DIRECTIVE DISCUSSED W PATIENT J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/28/2021 ADVANCE DIRECTIVE DISCUSSED W PATIENT
Around 9/26/17 at 8pm I noticed subtle changes in my smile (the left side of my mouth wasn't raised as high as my right side). The next morning on 9/27/17 my smile remained the same as previous night but I also noticed I wasn't able to close my left eyes all the way (when I washed my face water would get into my left eye because I wasn't able to shut it tightly). As a result of my eyes not shutting all the way I developed blurry vision in my left eye. I also had some difficulty swishing water in my mouth when brushing my teeth and spitting the water out. When I try to raise my eyebrows my left eyebrows wouldn't raise as high as my right eyebrow. I did not have any weakness on my limbs/extremities, no headache, no confusion/change in mental state, no pain, no difficulty swallowing or eating. I went to urgent care on 9/28/17 and they diagnosed me with Bell's Palsy and gave me steroids (prednisone taper starting at 60mg per day and tapered over a ten day period) and Valtrex (1000 mg once daily for 5 days). So far my symptoms reached its peak on 9/29/17 and as of today (10/3/17) symptoms have remained the same although vision feels a bit blurrier. I am using artificial tears every hour and wearing an eye patch at night.  I have follow up appointment with neurology specialist on 11/9/17.
sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a sponsored program (155558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 09Mar2021 (Batch/Lot number: unknown) as DOSE 1, SINGLE for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.